Skip to main content

Clinical aspects and predictors of mortality of Pseudomonas aeruginosa pneumonia in a cohort of critically ill patients

Introduction

Pseudomonas aeruginosa (PA) pneumonia (PN) represents a serious complication of long-term hospitalization [1]. The aim of our study is to analyze the clinical characteristics and predictors of mortality of PAPN in critically ill patients.

Methods

All patients admitted to the 18-bed ICU of our university hospital between 1 January 2009 and 30 June 2010, affected by PAPN, were retrospectively enrolled in a cohort study.

Results

Over the study period 1,109 patients were admitted and 322 bacterial PN were diagnosed. Sixty-five PAPN occurred: 52 ICU-acquired (ICUa) and 13 non-ICU-acquired (nICUa). Patients were mainly admitted because of a medical condition (71%), with a median length of ICU stay of 29.2 ± 27.6 days. The median SAPS II and SOFA scores were 40 ± 13.5 and 6.2 ± 3. A total of 35.4% of PA isolated were multidrug-resistant (MDR), 49.2% of patients with PAPN received a >24 hour delayed adequate antimicrobial treatment (DAAT >24 hours) and 57% received an anti-pseudomonas combination therapy; 25 patients (38.5%) died in the ICU. Comparing patients with ICUaPN with those with nICUaPN, the former group were younger (P < 0.01), with a longer length of ICU stay (P < 0.01), more frequently admitted for a traumatic reason (P = 0.02) and presented less severe SAPS II (P < 0.05). The independent risk factors associated with ICU mortality are listed in Table 1.

Table 1 Chronic renal failure (CRF)

Conclusions

PA has appeared as a relevant respiratory pathogen in our cohort of critically ill patients, either in ICU or pre/ICU settings. Patients' (baseline clinical condition), PA (MDR) and physicians' (DAAT >24 hours) related factors can influence the outcome of PN. The knowledge of local bacterial epidemiology and the prompt use of an anti-pseudomonas empiric treatment in patients with recognized PA risk factors could improve the outcome of severe MDR PAPN.

References

  1. 1.

    Jones RN: Clin Infect Dis. 2010, 51: S81-S87. 10.1086/653053

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to G De Pascale.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

De Pascale, G., Antonicelli, F., Maviglia, R. et al. Clinical aspects and predictors of mortality of Pseudomonas aeruginosa pneumonia in a cohort of critically ill patients. Crit Care 15, P184 (2011). https://doi.org/10.1186/cc9604

Download citation

Keywords

  • Pneumonia
  • Independent Risk Factor
  • Pseudomonas Aeruginosa
  • Related Factor
  • Median Length